Nanobiotix

Paris
France

Show jobs for this employer

206 articles about Nanobiotix

Nanobiotix Revenue For Q2 2015

7/15/2015
Nanobiotix Reports Positive Preliminary Results In Head And Neck Cancer Phase I/II Clinical Trial With NBTXR3

6/9/2015
Nanobiotix Revenue For The 1st Quarter Of 2015

5/13/2015
Nanobiotix: 2014 Annual Results

4/14/2015
Nanobiotix Appoints Its Manufacturing Partner, Cordenpharma : Another Step Towards Commercialization

3/18/2015
Nanobiotix 2014 Q4 And Annual Revenues

2/27/2015
Professor Robert Langer Joins Nanobiotix As Scientific Advisor

2/20/2015
Nanobiotix Places Shares And Warrants With U.S. Investor

12/1/2014
Nanobiotix Receives First Approval To Start Phase 2/3 Registration Trial In Soft Tissue Sarcoma In Europe

10/16/2014
Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers

10/13/2014
PharmaEngine, Inc. Will Join Nanobiotix' Pivotal Trial For NBTXR3 In Soft Tissue Sarcoma To Accelerate Its Development In Asia-Pacific

10/8/2014
Nanobiotix Expands Operations Into The U.S.A. As Part Of Its International Development Strategy

9/22/2014
Nanobiotix Half Year Results For The Six Months Ended 30 June 2014

8/29/2014
Nanobiotix Revenue For The 2nd Quarter Of 2014

7/11/2014
Nanobiotix Presents Successful Phase I Results For Its Lead Nanomedicine Product NBTXR3 At American Society of Clinical Oncology

6/2/2014
Nanobiotix: Sees Clinical Advance In Soft Tissue Sarcoma Pilot Trial With Lead Product, NBTXR3 Market Development Plan Outlined For Earlier Potential Launch In 2016

2/11/2014
Nanobiotix Sees Clinical Advance In Soft Tissue Sarcoma Pilot Trial With Lead Product, NBTXR3

2/11/2014
Nanobiotix Strengthens Its Supervisory Board For The Next Stage Of Its Development

1/16/2014
Nanobiotix 2013 Review: Significant Corporate And Clinical Progress

1/7/2014
Nanobiotix :Strengthens Its Nanoxray Pipeline With The Launch Of NBTX-TOPO Development, The First Nanotherapeutic With Embedded Radar

12/6/2013